Fundraising Fox
CellCarta
1 known investors
Find your way into CellCarta
Sign up to see every warm intro you have to CellCarta
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CellCarta team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CellCarta is a contract research organization providing biomarker discovery, assay development, and clinical trial execution services for pharmaceutical companies and biotechs. It offers multi-omic biomarker insights, regulatory-ready data generation, and regulatory support for assay development and IVDR submissions across preclinical and clinical therapeutic programs.
Founders & leadership
Investors · 1
In the news
Frequently asked questions
- What does CellCarta do?
- CellCarta is a contract research organization providing biomarker discovery, assay development, and clinical trial execution services for pharmaceutical companies and biotechs. It offers multi-omic biomarker insights, regulatory-ready data generation, and regulatory support for assay development and IVDR submissions across preclinical and clinical therapeutic programs.
- Who founded CellCarta?
- CellCarta was founded by Martin LeBlanc.
- Who are CellCarta's investors?
- CellCarta's investors include Arsenal.